The field of tissue injury in the lung and airway

Cancer Prevention Research

Volumn 1, Issue 6, 2008, Pages 396-403

  Steiling, Katrina ^a,b   Ryan, John ^a   Brody, Jerome S ^a   Spira, Avrum ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CANCER DIAGNOSIS; CELL PROLIFERATION; CELL TRANSFORMATION; ENVIRONMENT; GENETICS; GENOMICS; HUMAN; LUNG; LUNG TUMOR; METABOLISM; MOUTH MUCOSA; PATHOLOGY; PRECANCER; RESPIRATORY TRACT MUCOSA; REVIEW; SMOKING;

CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EARLY DETECTION OF CANCER; ENVIRONMENT; GENOMICS; HUMANS; LUNG; LUNG NEOPLASMS; MODELS, BIOLOGICAL; MOUTH MUCOSA; PRECANCEROUS CONDITIONS; RESPIRATORY MUCOSA; SMOKING;

EID: 61749088394     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0174     Document Type: Review

References (69)

1. Slaughter DP, Southwick HW, Smejkai W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:693-8.
2. Slaughter DP. The multiplicity of origin of malignant tumors: collective review. Internat Abstr Surg 1944;79:89-98.
3. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL. Clinical implications and utility of field cancerization. Cancer Cell Int 2007;7:2.
4. Shields PG. Molecular epidemiology of lung cancer. Ann Oncol 1999;10 Suppl 5:S7-11.
5. Gray J, Mao JT, Szabo E, et al. Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132: 56-68S.
6. Neft RE, Crowell RE, Gilliland FD, et al. Frequency of trisomy 20 in nonmalignant bronchial epithelium from lung cancer patients and cancer-free former uranium miners and smokers. Cancer Epidemiol Biomarkers Prev 1998;7:1051-4.
7. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
8. Moss SF, Blaser MJ. Mechanisms of disease inflammation and the origins of cancer. Nat Clin Pract Oncol 2005;2:90-7.
9. Li Q, Withoff S, Verma IM. Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol 2005;26:318-25.
10. DeMarini DM, Landi S, Tian D, et al. Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions. Cancer Res 2001;61:6679-81.
11. Keohavong P, Lan Q, Gao WM, et al. K-ras mutations in lung carcinomas from nonsmoking women exposed to unvented coal smoke in China. Lung Cancer 2003;41:21-7.
12. Keohavong P, Lan Q, Gao WM, et al. Detection of p53 K-ras mutations in sputum of individuals exposed to smoky coal emissions in Xuan Wei County, China. Carcinogenesis 2005;26:303-8.
13. Nelson MA, Wymer J, Clements N. Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers. Cancer Lett 1996;105: 115-21.
14. Franklin WA, Gazdar AF, Haney J, et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997;100:2133-7.
15. Wistuba II, Lam S, Behrens C, et al. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997;89: 1366-73.
16. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-62.
17. Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005;65:7568-72.
18. Masayesva BG, Mambo E, Taylor RJ, et al. Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev 2006;15:19-24.
19. Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000;287: 2017-9.
20. Yashima K, Litzky LA, Kaiser L, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997;57:2373-7.
21. Miyazu YM, Miyazawa T, Hiyama K, et al. Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res 2005;65: 9623-7.
22. Guo M, House MG, Hooker C, et al. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res 2004;10: 5131-6.
23. Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62:2370-7.
24. Bhutani M, Pathak AK, Fan YH, et al. Oral epithelium as a surrogate tissue for assessing smokinginduced molecular alterations in the lungs. Cancer Prev Res 2008;1:39-44.
25. Kopelovich L, Henson DE, Gazdar AF, et al. Surrogate anatomic/functional sites for evaluating cancer risk: an extension of the field effect. Clin Cancer Res 1999;5:3899-905.
26. Chang YL, Wu CT, Lin SC, et al. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers. Clin Cancer Res 2007;13: 52-8.
27. Wang X, Christiani DC, Mark EJ, et al. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma. Cancer 1998;85:1734-9.
28. Mitsudomi T, Yatabe Y, Koshikawa T, et al. Mutations of the p53 tumor suppressor gene as a clonal marker for multiple primary lung cancers. J Thorac Cardiovasc Surg 1997;114:354-60.
29. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315: 1650-9.
30. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454: 436-44.
31. Powell CA, Klares S, O'Connor G. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. Clin Cancer Res 1999;5:2025-34.
32. Stearman RS, Dwyer-Nield L, Grady MC, Malkinson AM, Geraci MW. A macrophage gene expression signature defines a field effect in the lung tumor microenvironment. Cancer Res 2008;68:34-43.
33. Engels EA, Wu X, Gu J, et al. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res 2007;67:6520-7.
34. Hackett NR, Heguy A, Havey BG, et al. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol 2003;29:331-43.
35. Spira A, Beane J, Shah V, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A 2004;101: 10143-8.
36. Sridhar S, Schembri F, Zeskind J, et al. Smokinginduced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics 2008;9:259.
37. Beane J, Sebastiani P, Liu G, et al. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol 2007;8.
38. Chari R, Lonergan KM, Ng RT, et al. Effect of active smoking on the human bronchial epithelium transcriptome. BMC Genomics 2007;8:297.
39. Harvey BF, Heguy A, Leopold LP, et al. Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med 2006;85:39-53.
40. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-6.
41. Neugut AI, Sherr D, Robinson E, Murray T, Nieves J. Differences in histology between first and second primary lung cancer. Cancer Epidemiol Biomarkers Prev 1992;1:109-12.
42. Auerbach O, Hammond EC, Kirman D, Garfinkel L. Effect of cigarette smoking on dogs. II. Pulmonary neoplasms. Arch Environ Health 1970;21: 754-68.
43. von Zeidler SV, Miracca EC/Nagai MA, Birman EG. Hypermethylation of the p16 gene in normal oral mucosa of smokers. Int J Mol Med 2004;14: 807-11.
44. Belinsky SA, Liechty KC, Gentry FD, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006;66:3338-44.
45. Merrick DT, Haney J, Petrunich S, et al. Overexpression of vascular endothelial growth factor and its receptors in bronchial dysplasia demonstrated by quantitative RT-PCR analysis. Lung Cancer 2005;48:31-45.
46. Martinet N, Bonnard L, Regnaul V, et al. In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer. Am J Respir Cell Mol Biol 2003; 28:428-35.
47. Rahman SMJ, Shyr Y, Yildiz PB, et al. Proteomic patterns of preinvasive bronchial lesions. Am J Respir Crit Care Med 2005;172:1556-62.
48. Beane J, Sebastiani P, Whitfield TH, et al. A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev Res 2008;1:56-64.
49. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
50. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathologic staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-35.
51. Seike M, Yanaihara N, Bowman EDZK, et al. Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst 2007;99: 1257-69.
52. Baryshnikova E, Destro A, Infante MV, et al. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Clin Cancer Res 2008;14: 1913-9.
53. Merrick DT, Kittelson J, Winterhalder R, et al. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. Clin Cancer Res 2006;12:2281-8.
54. Siegfried JM. Biology and chemoprevention of lung cancer. Chest 1998;113:40-5S.
55. Chan AT, Ogino S, Fuchs CS. Aspirin and risk of colon cancer in relation to expression of COX-2. N Engl J Med 2007;356:2131-42.
56. Vogel U, Christensen J, Wallin H, et al. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 2008;639:89-100.
57. Maksimova E, Yie TA, Rom WN. In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent. Lung 2008;186:45-54.
58. Gustafson AM, Lam S, McWilliams A, et al. Deregulation of phosphatidylinositol 3-kinase pathway in the airway epithelium of smokers is associated with lung cancer. Am J Respir Crit Care Med 2008;Abstracts Issue:A541.
59. Avan N, Avan I, Alatli C, et al. P53 overexpression in normal oral mucosa of heavy smokers. J Exp Clin Cancer Res 2000;19:525-9.
60. Colucci S, El-Gehani R, Flint S, Mothersill C. p53 mutations and protein expression in primary cultures of normal oral mucosa in smokers and nonsmokers. Oral Oncol 1997;33:240-6.
61. Spira A, Beane J, Schembri F, et al. Noninvasive method for obtaining RNA from buccal mucosaepithelial cells for gene expression profiling. Biotechniques 2004;36:484-7.
62. Jain RJ, Varma S, Hurteau GJ, Spivack S. Buccal-lung comparison of quantitative expression of carcinogen and oxidant metabolism genes in human subjects. Chest 2004;125:107-8.
63. Spivack SD, Hurteau GJ, Jain R, et al. Geneenvironment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosa cells. Cancer Res 2004;64:6805-13.
64. Spitz MR, Etzel CJ, Dong Q, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res 2008;1:250-4.
65. Zhang L, Lee JJ, Tang H, et al. Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers. Cancer Prev Res 2008;1:112-8.
66. Gumus ZH, Du B, Kacker A, et al. Effects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia. Cancer Prev Res 2008;1:100-11.
67. Penning TM, Lerman C. Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment. Cancer Prev Res 2008;1: 80-3.
68. Pierrou S, Broberg P, O'Donnell RA, et al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:577-86.
69. Herbst RS, Heymach JV, Lippman SM. Molecular origins of cancer: lung cancer. N Engl J Med 2008; 359:1367-80.